Medtronic PRESTIGE Artificial Disc

A Post-Approval Investigation of the PRESTIGE® Cervical Disc Device at Single Level for Symptomatic Cervical Disc Disease

Sponsor: Medtronic

The study looked at the long-term safety and effectiveness of the PRESTIGE® Cervical Disc to treat degenerative disc disease in the cervical spine. The original investigational study evaluated the use of the PRESTIGE® Cervical Disc at a single level compared to fusions with allograft bone. The goal was to show the success rate for the PRESTIGE disc is no worse than fusions.

The PRESTIGE disc received FDA approval in July 2007. Patients were followed for 7 years post-operative, and Dr. Foley’s site completed this requirement and was closed by the sponsor in May 2011.